By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Meridian Bioscience today reported that its fourth-quarter revenues declined 16 percent year over year, missing analysts' consensus estimate.

The Cincinnati-based diagnostics firm brought in total revenues of $35.5 million for the three months ended Sept. 30, compared to $42.5 million for the fourth quarter of 2009. It missed analysts' consensus estimate of $38.4 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A survey examines how age, political leanings, and more influence how Americans view certain scientific topics, the Associated Press reports.

A researcher who pleaded guilty to making false statements in research reports has been sentenced to four and a half years in prison and must pay $7.2 million back to the NIH.

The BabySeq project to study the risks and benefits of sequencing newborns is underway.

In Nature this week: association between genome-wide homozygosity and traits like height and cognitive ability, improved CRISPR-Cas9 editing, and more.